The Call That Changed Everything
On 14 May 2026, laboratory technicians in Bunia, the capital of the Democratic Republic of Congo's Ituri province, confirmed what field epidemiologists had feared for days: the haemorrhagic fever tearing through remote villages was not the Zaire ebolavirus that the world had fought in previous outbreaks, but Bundibugyo virus, a rarer and less understood variant . Within seventy-two hours, the first cases appeared across the border in Uganda . By 17 May, the World Health Organization had seen enough. Director-General Tedros Adhanom Ghebreyesus convened an emergency committee, and two days later — with unusual speed — declared the outbreak a Public Health Emergency of International Concern .
It was the first PHEIC declaration for Ebola since the devastating 2018–2020 outbreak in North Kivu, and the first ever for Bundibugyo virus. The speed of the declaration reflected both institutional learning and deep anxiety. "The world cannot afford to look away," warned officials in Brussels as the European Union began coordinating its response . What began as a cluster of unexplained deaths in Ituri's forested borderlands had become, in less than a week, a global emergency.
By late June, the numbers told a grim story. The Democratic Republic of Congo's Ministry of Health reported 1,155 confirmed cases and 304 deaths as of 24 June . Other tallies placed the count at 1,200 cases . The outbreak had spread across multiple regions of eastern DRC , and Uganda had recorded seven confirmed cases of the Bundibugyo variant . An attack on a burial team and the flight of eleven patients from care in Congo underscored the volatility on the ground . Médecins Sans Frontières issued stark warnings about the "rapid spread" causing "deep alarm" amongst healthcare workers . Africa's top health agency formally declared the crisis, and governments from Kampala to Kathmandu began scrambling to fortify their defences .
What made this outbreak different was not just the variant — Bundibugyo had caused only a handful of documented outbreaks since its identification in 2007 — but the constellation of vulnerabilities it exposed. The international response machinery, honed over years of battling Zaire ebolavirus, suddenly found itself calibrating therapies, vaccines and protocols for a pathogen with a thinner evidence base and no proven treatment regimen. The fault lines between preparedness and reality opened wide.
The Border That Closed
On a date in late May or early June — the exact timing obscured by the fog of crisis management — Uganda made a decision that reverberated across the region: it closed its border with the Democratic Republic of Congo . The move was dramatic, economically costly, and epidemiologically fraught. Exceptions were carved out for response teams and essential humanitarian workers , but the message was unmistakable: containment had become the priority, even at the expense of the cross-border commerce and kinship ties that define life in the Great Lakes region.
The closure was both symbol and substance. Uganda had bitter experience with Ebola; outbreaks in 2000, 2007, 2012 and 2022 had tested its health system and left scars in the national memory. The government was not prepared to gamble on goodwill and surveillance alone. Yet the border closure also highlighted a central tension in outbreak response: the impulse to erect barriers often conflicts with the epidemiological imperative to maintain visibility and access. Sealed borders can drive cases underground, complicating contact tracing and case detection. They can also fuel resentment and resistance in communities that see checkpoints as impositions rather than protections.
The decision triggered a cascade of defensive measures worldwide. In Hong Kong, authorities ramped up health checks for travellers arriving from Africa, deploying thermal scanners and symptom questionnaires at the airport . Within days, the city announced preparations to activate a quarantine facility on Lantau Island, a signal of how seriously officials took the threat . Singapore and other Asian nations followed suit, stepping up Ebola screening protocols after the WHO declaration . In Kerala, health authorities announced that all travellers from affected nations would be monitored for twenty-one days — the maximum incubation period for Ebola .
Further afield, responses ranged from heightened vigilance to outright alarm. Nepal's health ministry stepped up surveillance . Ghana issued an alert . Gabon reinforced sanitary monitoring along its borders . Panama's health agency, Minsa, maintained active protocols and surveillance , whilst Costa Rica's authorities sought to reassure the public that the risk remained low . Denmark's health agency issued guidance to travellers , and Sweden's Folkhälsomyndigheten published information for those heading to affected regions . Even nations with no direct flight links to central Africa found themselves fielding questions and updating contingency plans.
The global reflex was revealing. A decade and a half after the West African Ebola crisis exposed catastrophic gaps in preparedness, the muscle memory of panic remained. Yet the response was more organised this time, more systematic — a testament to reforms enacted after 2014. That did not mean it was sufficient.
The Therapeutics Scramble
In a conference room in Geneva on 20 May, and again on 26 May, the WHO Technical Advisory Group on therapeutics convened to assess what tools existed to fight Bundibugyo virus . The list was sobering: remdesivir, obeldesivir, MBP-134, maftivimab, and Inmazeb — all candidates for clinical research, none yet proven effective against this particular variant . The meetings underscored an uncomfortable truth: the world's pharmacological arsenal had been calibrated for Zaire ebolavirus, which caused the majority of outbreaks and fatalities. Bundibugyo, responsible for a single documented outbreak in Uganda in 2007 with a case-fatality rate around 25 per cent, had attracted far less research investment.
This was not neglect, exactly, but a rational allocation of scarce resources towards the likeliest threat. The problem was that rationality offered little comfort when the unlikely threat materialised. Remdesivir, a broad-spectrum antiviral, had shown promise in laboratory studies but lacked robust clinical trial data for Bundibugyo. Monoclonal antibody therapies like maftivimab and the cocktail Inmazeb had been developed primarily against Zaire ebolavirus; their efficacy against Bundibugyo remained speculative. Researchers scrambled to model scenarios and project the outbreak's trajectory , but modelling could only guide decisions, not replace the drugs and vaccines that did not yet exist.
The therapeutics gap was mirrored by a deeper infrastructure deficit. Ituri province, the outbreak's epicentre, is a patchwork of artisanal mining zones, displacement camps, and villages with minimal health services. Armed groups contest territory; roads are unreliable; trust in government authorities is thin. Building the logistics to deliver even existing therapies — cold chains for temperature-sensitive biologics, trained clinicians to administer them, community mobilisers to convince frightened populations to seek care — was a Herculean task. The attack on the burial team was a violent reminder that epidemiological interventions unfold in political contexts, and that those contexts can be lethally uncooperative.
Médecins Sans Frontières, which had deployed teams early, reported that the rapid spread was causing profound alarm amongst its staff and local healthcare workers . The psychological burden of fighting Ebola is immense: the protective equipment is stifling, the mortality rates are harrowing, and the risk of infection is ever-present. A paediatrician who was isolated after potential exposure used their platform to call for greater support for colleagues in Congo, highlighting the human cost of the response . The plea went largely unheeded in the international press, drowned out by the noise of border closures and case counts.
The Geopolitics of Contagion
In Nairobi, a demonstration against a proposed United States-funded Ebola research centre turned deadly when police opened fire, killing one protester . The incident, reported briefly and then forgotten in the churn of the outbreak news cycle, crystallised a broader unease: suspicion of foreign intervention, resentment of perceived exploitation, and fear that research facilities could themselves become vectors of disease. The shooting was a bleak echo of the conspiracy theories that had plagued earlier outbreaks, when rumours of deliberately spread infection and organ harvesting fuelled violence against health workers.
Elsewhere, the epidemic intersected with more prosaic concerns. In the Spanish city of Cádiz, officials expressed worry over a scheduled friendly football match between the Democratic Republic of Congo and Chile, fearing it could complicate public health messaging or even pose a transmission risk . The anxieties were likely overblown — Ebola is not airborne, and the teams would be subject to screening — but the episode illustrated how a health emergency refracts through every layer of society, from geopolitics to sport.
Spain's foreign ministry, meanwhile, moved to strengthen its response in concert with the International Federation of Red Cross and Red Crescent Societies, deploying resources to eastern Africa . The gesture was part of a broader pattern: wealthier nations offering technical assistance, funding, and personnel, often through multilateral channels that allowed them to demonstrate solidarity whilst maintaining diplomatic distance. The architecture of global health governance, forged in the fires of HIV/AIDS, SARS, and Ebola itself, was being stress-tested once more.
The Information Front
On social media and through official channels, a steady drumbeat of updates attempted to keep pace with the outbreak's evolution. The United States Centers for Disease Control and Prevention elevated its travel advisory to Level 3, recommending that U.S. citizens avoid non-essential travel to the Democratic Republic of Congo . The agency published situation reports and collaborated with international partners to model the outbreak's potential trajectories . In Denmark, newspapers and health authorities briefed the public on what the international health crisis designation meant . The Straits Times, the BBC, and outlets across Latin America, Europe and Asia carried updates, often repeating the same core facts but serving distinct audiences with different threat perceptions .
The information environment was more transparent than in previous outbreaks, but it was also noisier. Daily Ebola updates proliferated on platforms like X, some authoritative, others speculative or sensationalist . The challenge for public health officials was not simply to inform but to calibrate: too much alarm risked panic and stigmatisation of affected communities; too little risked complacency. The WHO's situation reports walked this tightrope, emphasising vigilance without catastrophising .
One striking feature of the response was its unevenness. Wealthy Asian city-states like Hong Kong and Singapore moved with alacrity, deploying screening technology and activating quarantine infrastructure within days . India's Kerala state, with experience managing Nipah virus outbreaks, implemented a 21-day monitoring protocol for incoming travellers . In contrast, many African nations beyond the outbreak's immediate periphery — lacking resources, competing crises, or both — issued alerts but struggled to implement robust surveillance . The global health system, for all its multilateral rhetoric, remained profoundly unequal.
The Long Shadow
By late June, as the case count climbed past 1,200 and the death toll approached 350, the outbreak showed no sign of abating. Relief organisations published detailed assessments of vulnerabilities in eastern DRC, cataloguing displacement, food insecurity, and the fragmentation of health services . The context was damning: Ituri province was simultaneously grappling with measles, cholera, malaria, and the aftershocks of decades of conflict. Ebola was not an isolated emergency but one thread in a dense weave of crises.
Yet the international response remained narrowly focused on containment and case management, with less attention paid to the structural fragilities that allowed outbreaks to take root. The question of why Bundibugyo virus emerged when and where it did — whether deforestation, climate shifts, or ecological disruption played a role — received scant public discussion. The therapeutics gap, the result of years of underinvestment in neglected pathogens, was treated as an unfortunate given rather than a policy failure. The border closures, the screening regimes, the modelling exercises: all were reactive, not preventive.
There was, nonetheless, a flicker of optimism. The speed of the PHEIC declaration, the rapid deployment of expert teams, the coordination between national health agencies and multilateral bodies — all suggested that the lessons of 2014 had not been entirely forgotten. The WHO's Technical Advisory Group was already identifying research priorities and accelerating pathways for experimental therapies . If the outbreak could be contained to Ituri and its immediate surroundings, if Uganda's border measures and regional surveillance held, if the rains did not worsen logistics further, then perhaps the worst could be averted.
But "perhaps" is a thin reed on which to rest the lives of thousands. The 2026 Ebola epidemic, caused by a variant the world was not prepared for, in a region the world has repeatedly failed, is a mirror held up to the global health order. What it reflects is not reassuring: a system capable of declaring emergencies and convening committees, but far less adept at addressing the inequities and blind spots that allow emergencies to occur. The outbreak is not over. The reckoning, in many ways, has only just begun.
"The rapid spread of Ebola is causing deep alarm amongst healthcare workers."
What Comes Next
As June turned towards July, the immediate task remained brutally simple: find every case, trace every contact, isolate and treat the sick, bury the dead safely. In Ituri's dense forests and crowded displacement camps, that task was anything but simple. The eleven patients who fled care represented not just epidemiological risk but a vote of no confidence in the response itself. Winning back that confidence — through culturally sensitive messaging, through visible support for affected communities, through transparency about what is known and what is not — is as crucial as any vaccine or antiviral.
The international community, for its part, faces a choice. It can treat this outbreak as an aberration, a piece of bad luck that will pass, and return to the status quo once the case counts decline. Or it can recognise the 2026 Bundibugyo epidemic as a warning: that the next variant, the next spillover, the next convergence of pathogen and vulnerability, is not a question of if but when. That choice will determine whether the machinery of global health becomes more resilient or simply better at managing crises it could have prevented.
For now, the world watches the numbers. In Hong Kong, quarantine beds stand ready on Lantau Island. In Kerala, health workers monitor returning travellers. In Kampala, the border remains closed. And in Ituri, in villages whose names most of the world cannot pronounce, people are dying of a disease the world has known about for nearly two decades but never quite bothered to master. The epidemic is a test. The results, so far, are mixed.